Full Text View
Tabular View
No Study Results Posted
Related Studies
Dose-Ranging Study of Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine
This study has been completed.
Study NCT00365716   Information provided by Merck
First Received: August 16, 2006   Last Updated: October 1, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Papillomavirus Infections
Genital Diseases, Female
Additional conditions recognized in this trial
Infection
More general conditions related to this trial
DNA Virus Infections
Tumor Virus Infections
Virus Diseases
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services